Skip to content
StockMarketAgent
Sector pending / Electromedical and Electrotherapeutic ApparatusUpdated 2026-05-10 22:07 UTC

FRA/SHL1 stock hub

FRA/SHL1 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/SHL1is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
37.5B
Frankfurt Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
FRA/SHL1
In the news

Latest news · FRA/SHL1

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.6
P25 n/aP50 n/aP75 n/a
Trailing P/E17.9
P25 n/aP50 n/aP75 n/a
ROE11.5
P25 n/aP50 n/aP75 n/a
ROIC7.4
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/SHL1 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
214
Groups with data
11
Currency
EUR
Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Germany
Country code
DE
Employees
72,369
Employees Change
-40%
Employees Change Percent
-0.05
Enterprise value
EUR 51B
Exchange
Frankfurt Stock Exchange
Financial currency
EUR
First seen
2026-05-10
Industry
Electromedical and Electrotherapeutic Apparatus
Last refreshed
2026-05-10
Market cap
EUR 37.5B
Price
EUR 16.5
Price currency
EUR
Rev Per Employee
311,702.7x
Sic
3845
Symbol
fra/SHL1
Website
https://www.siemens-healthineers.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
5.58%
EV Earnings
24.34x
EV/EBIT
16.91x
EV/EBITDA
12.51x
EV/FCF
21.02x
EV/Sales
2.21x
FCF yield
6.46%
Forward P/E
13.64x
P/B ratio
2.06x
P/E ratio
17.92x
P/S ratio
1.63x
PE Ratio10 Y
29.59x
PE Ratio3 Y
29.54x
PE Ratio5 Y
30.96x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
13.11%
EBITDA Margin
16.8%
FCF margin
10.52%
Gross margin
38.03%
Gross Profit
EUR 8.8B
Gross Profit Growth
-2.24%
Gross Profit Growth Q
-7.79%
Gross Profit Growth3 Y
4.57%
Gross Profit Growth5 Y
8.68%
Net Income
EUR 2.1B
Net Income Growth
0.29%
Net Income Growth Q
-4.53%
Net Income Growth3 Y
11.31%
Net Income Growth5 Y
5.89%
Pretax Margin
11.94%
Profit Margin
9.08%
Profit Per Employee
EUR 28,311
ROA
4.12
Roa5y
3.95
ROCE
9.47
ROE
11.47
Roe5y
10.88
ROIC
7.43
Roic5y
6.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

21
MetricValue
Cagr1y
-30.78%
Cagr3y
-15.33%
Cagr5y
-6.28%
Div CAGR3
3.16%
Div CAGR5
2.98%
EPS Growth
0.2
EPS Growth Q
-4.26
EPS Growth3 Y
11.29
EPS Growth5 Y
4.38
FCF Growth
-12.73%
FCF Growth Q
96.97%
FCF Growth3 Y
20.92%
FCF Growth5 Y
3.21%
OCF Growth
-9.03%
OCF Growth Q
45.55%
OCF Growth3 Y
12.78%
OCF Growth5 Y
3.82%
Revenue Growth
-0.33x
Revenue Growth Q
-3.86x
Revenue Growth3 Y
2.2x
Revenue Growth5 Y
8.96x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
EUR 0.5
Assets
EUR 44.8B
Cash
EUR 1.9B
Current Assets
EUR 14.2B
Current Liabilities
EUR 12.9B
Debt
EUR 15.3B
Debt EBITDA
EUR 3.75
Debt Equity
EUR 0.84
Debt FCF
EUR 6.32
Equity
EUR 18.3B
Interest Coverage
7.4
Liabilities
EUR 26.6B
Long Term Assets
EUR 30.6B
Long Term Liabilities
EUR 13.7B
Net Cash
EUR -13.4B
Net Cash By Market Cap
EUR -35.74
Net Debt EBITDA
EUR 3.46
Net Debt Equity
EUR 0.73
Net Debt FCF
EUR 5.53
Tangible Book Value
EUR -5.6B
Tangible Book Value Per Share
EUR -4.99

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.1
Inventory Turnover
3.19
Net Working Capital
EUR 3.3B
Quick ratio
0.66
Working Capital
EUR 1.3B
Working Capital Turnover
EUR 17.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-0.01%
Dividend Growth
9.44%
Dividend Growth Years
1%
Dividend per share
EUR 0.31
Dividend Years
8
Dividend Yield
1.8%
Ex Div Date
2026-02-09
Last Dividend
EUR 0.31
Payout Frequency
Annual
Payout Ratio
53.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
-30.76%
200-day SMA
21.46
3Y total return
-39.31%
50-day SMA
18.58
50-day SMA vs 200-day SMA
50under200
5Y total return
-27.71%
All Time High
34.2
All Time High Change
-51.75%
All Time High Date
2022-01-05
All Time Low
14.3
All Time Low Change
15.38%
All Time Low Date
2020-03-16
ATR
0.56
Ch YTD
-24.31
High
16.5
High52
25.2
High52 Date
2025-05-22
High52ch
-34.52%
Low
16.5
Low52
16.5
Low52 Date
2026-05-08
Low52ch
0%
Ma50ch
-11.19%
Price vs 200-day SMA
-23.13%
RSI
38.77
RSI Monthly
32.3
RSI Weekly
32.46
Sharpe ratio
-0.82x
Sortino ratio
-0.93
Total Return
1.79%
Tr YTD
-23.14
Tr1m
-6.25%
Tr1w
-4.07%
Tr3m
-17.87%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 3B
Operating Income Growth
-4.45
Operating Income Growth Q
-13.74
Operating Income Growth3 Y
11.56
Operating Income Growth5 Y
6.44
Operating margin
13.11

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

5
MetricValue
Float
176,825,834%
Net Borrowing
-1,059,000,000
Shares Institutions
13.08%
Shares Qo Q
0.17%
Shares Yo Y
0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

55
MetricValue
Adjusted FCF
EUR 2.4B
Average Volume
179.8x
Bv Per Share
16.2
CAPEX
EUR -797M
Ch1m
-6.25
Ch1w
-4.07
Ch1y
-31.82
Ch3m
-19.12
Ch3y
-41.49
Ch5y
-31.82
Ch6m
-28.26
Change
-1.2%
Change From Open
0
Close
16.7
Days Gap
-1.2
Depreciation Amortization
850,000,000
Earnings Date
2026-05-07
EBIT
EUR 3B
EBITDA
EUR 3.9B
EPS
EUR 1.86
F Score
7
FCF
EUR 2.4B
FCF EV Yield
4.76x
Financing CF
-2,916,000,000
Fiscal Year End
September
Founded
1,896
Goodwill
17,310,000,000
Graham Number
12.89773
Graham Upside
-21.83
Income Tax
EUR 633M
Investing CF
-730,000,000
Is Primary Listing
0
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Lynch Fair Value
EUR 5.42
Lynch Upside
-67.15
Ma150
20.86
Ma150ch
-20.91%
Ma20
18.02
Ma20ch
-8.41%
Net CF
-496,000,000
Next Earnings Date
2026-07-31
Open
16.5
P FCF Ratio
15.47
P OCF Ratio
11.65
Payment Date
2026-02-24
Ppne
4,840,000,000
Price Date
2026-05-08
Price EBITDA
EUR 9.69
Relative Volume
0.13x
Revenue
23,066,000,000x
Tax By Revenue
2.74x
Tax Rate
22.99%
Tr6m
-27.15%
Z Score
2
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

FRA/SHL1 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.8%
$0.31 annual per share
Payout ratio
+53.4%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+3.0%
1 consecutive years of growth
Total shareholder yield
+1.8%
Next ex-dividend date: 2026-02-09
Performance

FRA/SHL1 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-30.8%
S&P 500 1Y: n/a
3Y total return
-39.3%
S&P 500 3Y: n/a
5Y total return
-27.7%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns FRA/SHL1?

Insider, institutional, and short-interest positioning.

Institutional ownership
+13.1%
Share of float held by funds and institutions
Insider ownership
n/a
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.0%
Negative means the company is buying back shares.
Technical

FRA/SHL1 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
38.8
Neutral momentum band
Price vs 200-day MA
-23.1%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
-0.82
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/SHL1

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/SHL1 stock rating?

fra/SHL1 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/SHL1 analysis?

The full report lives at /stocks/fra/SHL1/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/SHL1?

The latest report frames fra/SHL1 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/SHL1 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

fra/SHL1 stock profile: metrics, valuation and analysis | Hisse Senedi Piyasası AI Ajanı